A malaria vaccine based on stabilized proteins could be used in tropical places where there is no refrigeration.
Despite decades of malaria research, the disease still afflicts hundreds of millions and kills around half a million people each year – most of them children in tropical regions.
The best deterrent would be a vaccine composed of some of the parasite’s own proteins. However, those proteins identified as most promising for a malaria vaccine are unstable at tropical temperatures and require complicated, expensive cellular systems to produce them in large quantities.
Yet the vaccines are most needed in areas where refrigeration is lacking and funds to buy vaccines are scarce.—More…
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.Commenting Policy
Pursuant to Title 17 U.S.C. 107, other copyrighted work is provided for educational purposes, research, critical comment, or debate without profit or payment. If you wish to use copyrighted material from this site for your own purposes beyond the 'fair use' exception, you must obtain permission from the copyright owner. Views are those of authors and not necessarily those of Canada Free Press. Content is Copyright 1997-2017 the individual authors. Site Copyright 1997-2017 Canada Free Press.Com Privacy Statement